darmdoorlaatbaarheid wordt gemeten in gezonde mannen intestinal permeability irretable bowel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy as assessed by the - health and lifestyle questionnaire (P8738 F02; in Dutch) - results of the pre-study laboratory tests 2. Males aged >= 18 and = 20 and = 30 and
Exclusion criteria
Exclusion criteria: 1. Participation in any clinical trial including blood sampling and/or administration of substances up to 30-90 days before Day 01 of this study 2. Participation in any non-invasive clinical trial up to 30 days before Day 01 of this study, including no blood sampling and/or oral, intravenous, inhalator administration of substances 3. Having a history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease or hypertension, stomach and intestinal complaints (and medication), pre-diabetes and Diabetes Mellitus 4. Having stomach and/or intestinal complaints after consumption of a high-fat meal 5. Usage of NSAIDs and/or acetylsalicyl acid (for example ibuprofen, diclofenac, naproxen or aspirin) 6. Smoking 7. Alcohol consumption ( > 28 units/week) 8. Reported unexplained weight loss or gain of > 2 kg in the month prior to the pre-study screening 9. Reported slimming or medically prescribed diet 10. Recent blood donation (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intestinal permeability will be examined with an absorption test using four different sugars (sucrose, mannitol, sucralose and lactulose). New markers of intestinal permeability, like I-FABP, L-FABP, LPS and inflammatory markers will be measured as well. | — |
Secondary
| Measure | Time frame |
|---|---|
| Trait Anxiety inventory (baseline stress level as a character trait). Body resistance in relation with intestinal permeability. | — |
Countries
Netherlands